| Product Code: ETC9819964 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Turkey Neurological Disorder Drugs Market Overview |
3.1 Turkey Country Macro Economic Indicators |
3.2 Turkey Neurological Disorder Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Turkey Neurological Disorder Drugs Market - Industry Life Cycle |
3.4 Turkey Neurological Disorder Drugs Market - Porter's Five Forces |
3.5 Turkey Neurological Disorder Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Turkey Neurological Disorder Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Turkey Neurological Disorder Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Turkey Neurological Disorder Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Turkey Neurological Disorder Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Turkey Neurological Disorder Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Turkey |
4.2.2 Growing awareness and diagnosis of neurological disorders |
4.2.3 Technological advancements in the development of neurological disorder drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High cost associated with the development and manufacturing of neurological disorder drugs |
5 Turkey Neurological Disorder Drugs Market Trends |
6 Turkey Neurological Disorder Drugs Market, By Types |
6.1 Turkey Neurological Disorder Drugs Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.1.4 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F |
6.1.5 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F |
6.1.6 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.1.7 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Cerebrovascular Disease, 2021- 2031F |
6.1.8 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Turkey Neurological Disorder Drugs Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F |
6.2.3 Turkey Neurological Disorder Drugs Market Revenues & Volume, By NMDA Receptor Antagonists, 2021- 2031F |
6.2.4 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Antiepileptic, 2021- 2031F |
6.2.5 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Antipsychotic and Antidepressant, 2021- 2031F |
6.2.6 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Turkey Neurological Disorder Drugs Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Turkey Neurological Disorder Drugs Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Turkey Neurological Disorder Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.5 Turkey Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Turkey Neurological Disorder Drugs Market Import-Export Trade Statistics |
7.1 Turkey Neurological Disorder Drugs Market Export to Major Countries |
7.2 Turkey Neurological Disorder Drugs Market Imports from Major Countries |
8 Turkey Neurological Disorder Drugs Market Key Performance Indicators |
8.1 Number of clinical trials for neurological disorder drugs in Turkey |
8.2 Adoption rate of advanced treatment options for neurological disorders |
8.3 Investment in research and development for neurological disorder drugs in Turkey |
8.4 Number of partnerships and collaborations in the neurological disorder drug market in Turkey |
8.5 Patient adherence and compliance rates with prescribed neurological disorder medications |
9 Turkey Neurological Disorder Drugs Market - Opportunity Assessment |
9.1 Turkey Neurological Disorder Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Turkey Neurological Disorder Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Turkey Neurological Disorder Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Turkey Neurological Disorder Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Turkey Neurological Disorder Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Turkey Neurological Disorder Drugs Market - Competitive Landscape |
10.1 Turkey Neurological Disorder Drugs Market Revenue Share, By Companies, 2024 |
10.2 Turkey Neurological Disorder Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here